Menopause
Hormone therapy offers no protection against heart attacks
Published in Women's Health Weekly, August 1st, 2002
Postmenopausal women with coronary heart disease (CHD) should not take estrogen plus progestin hormone therapy to reduce their risk of CHD events, such as a nonfatal heart attack or death from coronary disease, according to an article in the July 3, 2002, issue of the Journal of the American Medical Association. In an accompanying report, long-term hormone therapy increased the risk for venous thromboembolism (blood clots) and gallbladder disease.
Deborah Grady, MD, MPH, of the University of California, San Francisco, and colleagues investigated whether the trend toward reduced risk of CHD events among women who were taking hormone therapy in the later years of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer Therapy
Interferon and endostatin gene therapy outpace angiostatin in breast cancers - Labor and Delivery
Continuous stitching method reduces pain for women with perineal damage after childbirth - Breast Cancer
Importance of early environmental exposure pinpointed - Cervical Cancer
Tissue changes may explain false-negative Pap smears - Endocrinology
Obese women with polycystic ovary syndrome benefit from naltrexone treatment - Obstetrics
Cesareans could make it more difficult to have other children - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
